Navigation Links
Mast Therapeutics Engages ESC Advisors To Identify Partnering Opportunities For MST-188
Date:3/28/2013

cy (endothelial dysfunction and/or impaired blood flow). 

The Company is recruiting subjects in EPIC, a pivotal phase 3 study of MST-188 in sickle cell disease. The Company plans to initiate a phase 2 clinical study of MST-188 in acute limb ischemia, a complication of peripheral arterial disease, in late 2013 or early 2014.  More information can be found on the Company's web site at www.masttherapeutics.com.  

Forward-Looking Statements
Mast Therapeutics cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on the Company's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding anticipated levels of interest in MST-188 among potential strategic partners in and outside of the U.S., the Company's and its advisors' focus and ability to capitalize on any such interest, prospects for MST-188's clinical, regulatory and commercial success in sickle cell disease and other indications, and the potential benefits of partnering MST-188.  Among the factors that could cause or contribute to material differences between the Company's actual results and expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: the potential for interest in MST-188 among potential strategic partners to be less than anticipated by the Company; the risk that acceptable partnering opportunities for MST-188 may not be available in particular jurisdictions or indications on a timely basis or at all and, consequently, the Company may not be able to pursue development of MST-188 in certain jurisdictions or indications; the potential that partnering transactions involving MST-188 may not advance its development in other jurisdictions, enhance the overall commercial opportunity of the
'/>"/>

SOURCE Mast Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics Secures $15 Million Loan Financing Agreement
2. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
3. DART Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy
4. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
5. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
6. Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
7. Echo Therapeutics Achieves ISO 13485 Certification
8. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
9. Echo Therapeutics Appoints Robert Doman to Board of Directors
10. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
11. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... AND PITTSBURGH , June 3, 2015 ... global pharmaceutical company, today announced that the Company will present ... on Tuesday June 9, 2015. The presentation is scheduled to ... Interested parties can access a live webcast of ... at http://mylan.com/investors .   Mylan is a ...
(Date:6/3/2015)... June 3, 2015  NxStage Medical, Inc. (Nasdaq: ... products , today announced data that home hemodialysis ... million gallons of water annually by transitioning just ... home hemodialysis with the NxStage® System One™.  Industry ... gallons of water per patient per week, whereas ...
(Date:6/3/2015)... , June 3, 2015 Genoa ... Pharmaceuticals, Inc., bringing together two pharmacy organizations with proven ... illness. Both companies have strong reputations for outstanding customer ... Genoa is the ... health community and those affiliated with managing the cost ...
Breaking Medicine Technology:Home Hemodialysis With NxStage System One Can Save California 221 Million Gallons of Water Annually 2Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2
... Keystone Symposia HIV Pathogenesis Conference, SAN ... ANX ) announced that it presented ... product candidate at the,Keystone Symposia HIV Pathogenesis ... The preclinical results demonstrate a unique resistance ...
... question with today,s ... ... uses a combination of catheter-mounted balloons and stents,to open a completely ... the best treatment for heart attack when performed rapidly.,However, few hospitals ...
Cached Medicine Technology:ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests 2ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests 3ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests 4Is PCI Safe, Effective After Clot-Busters for Heart Attack? 2Is PCI Safe, Effective After Clot-Busters for Heart Attack? 3
(Date:6/3/2015)... 2015 Hexagon Geospatial is pleased to ... its 2015 U.S. Education Challenge, which showcases the top ... or university in the U.S. , This year’s ... Remote Sensing and Civil Engineering at the University of ... Cracks Detection and Assessment Based on Hyper-spatial Resolution Natural ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Johnson & ... pay $7.8 million to resolve a Risperdal lawsuit ( ... tactics the company allegedly used to market the antipsychotic ... Court indicate that the Arkansas Attorney General moved to ... the accord. The Risperdal settlement amounts to just a ...
(Date:6/3/2015)... On June 22, 2015, Medicare will ... sensitivity (pharmacogenetic) testing that it has reimbursed since 2009. ... 19 million of the 49 million Medicare beneficiaries in the ... adverse drug events.(1) Sadly, if it became a standard of ... the use of an individual’s genetic information to tailor treatment, ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Array ... exchange technology, has announced that CEO Jonathan Rickert will ... 2015 on June 4, 2015. The session will ... technologies are disrupting traditional business models in health care, ... value. , WHAT: Digital Transformation and the Health ...
(Date:6/3/2015)... Peter Piot, MD, PhD, will be honored ... Meeting. DIA’s Global Inspire Award program recognizes the organization’s ... commitment to service on a global scale. ... Contribution to Global Health that recognizes those who have ... , “DIA is proud to honor Dr. ...
Breaking Medicine News(10 mins):Health News:Hexagon Geospatial Announces U.S. Education Challenge Winner at HxGN Live 2015 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... and is performed without anesthesia , , WEDNESDAY, Oct. 3 ... of an innovative form of colonoscopy that relies on ... , When it comes to detecting polyps that ... as effective as the traditional approach of using a ...
... It cuts rates of hospitalizations and deaths, study finds, , , WEDNESDAY, ... an annual flu shot will reduce the risk you,ll be hospitalized ... flu-related death by 48 percent. , That,s the conclusion of new ... England Journal of Medicine . , "This is a bad disease ...
... Calif., Oct. 3 Abaxis, Inc.,(Nasdaq: ABAX ... analysis systems, announced today the launch of the ... the Piccolo xpress(TM) point of,care analyzer. The ... imaging and,radiology centers in the United States to ...
... Acceptance of Umbilical Cord Blood Stem Cells as a Curative ... ... Inc. has been named,to Deloitte,s prestigious Technology Fast 50 Program for ... life sciences companies in the area by Deloitte & Touche USA ...
... CHICAGO, Oct. 3 President Bush,s veto today,of ... for millions of,children from families with low incomes ... dental health, says Oral Health America, a national,advocacy ... ten million children eligible for coverage through a,bipartisan, ...
... regarded as a barometer of a populations general health ... rate in 2006 was 5.9 infant deaths for every 1,000 ... made major progress in reducing infant deaths since the early ... but the decline has leveled off in recent years. The ...
Cached Medicine News:Health News:'Virtual' Colonoscopy an Effective Option: Study 2Health News:'Virtual' Colonoscopy an Effective Option: Study 3Health News:Flu Vaccine Does Protect Older People 2Health News:Flu Vaccine Does Protect Older People 3Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 3Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 2Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 3Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 4Health News:SCHIP Veto a Big Cavity for Children's Oral Healthcare, Advocates Say 2Health News:New York City's infant mortality rate declined in 2006 2Health News:New York City's infant mortality rate declined in 2006 3Health News:New York City's infant mortality rate declined in 2006 4
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... Spaced, Expandable, Multichannel Pipettor The ... boosts productivity with an industry breakthroughequal tip ... of a slide rod. This innovation allows ... between vessels with different configurations. Adjustable ...
... Comfort Pick one of our pipettors up ... trigger and ejector positionsright where they should beeven ... ergonomically designed to help avoid repetitive stress injuries ... In The Palm Of Your Hand Start ...
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
Medicine Products: